SCHEMBL7943820

SCHEMBL7943820

N#Cc1cc2c(cc1C#N)C(=O)NC2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP8 P40818 1/20 0.47
USP7 Q93009 1/20 0.47
PPOX P50336 1/20 0.41
GSK3B P49841 1/20 0.40
GRM5 P41594 4/20 0.38
KDM4E B2RXH2 3/20 0.38
HPGD P15428 3/20 0.38
ALDH1A1 P00352 2/20 0.38
GALR3 O60755 1/20 0.38
GAA P10253 1/20 0.38
EGFR P00533 4/20 0.36
TDP1 Q9NUW8 3/20 0.36
PRKD3 O94806 3/20 0.36
PRKCG P05129 3/20 0.36
PRKCB P05771 3/20 0.36
SRC P12931 3/20 0.36
PRKCA P17252 3/20 0.36
PRKCH P24723 3/20 0.36
PRKCI P41743 3/20 0.36
PRKCE Q02156 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15271277 0.76 USP7 (0.71) USP8USP7KDM4EHPGDALDH1A1
SCHEMBL13923619 0.75 CHEK1 (0.38) USP8USP7PPOXGSK3BGRM5
Phthalimide SCHEMBL3702599 0.75 GSK3B (0.65) USP8USP7GSK3BGRM5HPGD
SCHEMBL23968840 0.74 USP7 (0.75) USP8USP7KDM4EHPGDALDH1A1
SCHEMBL1263254 0.73 PPOX (0.38) USP8USP7PPOXGSK3BGRM5
SCHEMBL2809485 0.73 GRM5 (0.59) PPOXGSK3BGRM5TDP1CYP3A4
SCHEMBL8834544 0.72 EGFR (0.56) GSK3BGRM5KDM4EHPGDALDH1A1
SCHEMBL13606492 0.72 GSK3B (0.38) USP8USP7PPOXGSK3BNPSR1
SCHEMBL9489040 0.70 GSK3B (0.46) USP8USP7GSK3BKDM4EHPGD
SCHEMBL4961072 0.70 USP8 (0.38) USP8USP7KDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9315477-B2 Materials having electron deficient moieties and methods of synthesizing thereof GEORGIA TECH RESEARCH CORPORATION (US) 2016-04-19 US disclosed
US-20150218115-A1 MATERIALS HAVING ELECTRON DEFICIENT MOIETIES AND METHODS OF SYNTHESIZING THEREOF NATIONAL SCIENCE FOUNDATION 2015-08-06 US disclosed
US-6191307-B1 Process for making benzoic acids ALBEMARLE CORPORATION 2001-02-20 US disclosed
US-4132711-A Process for preparing nitriles SUNTECH, INC. (US) 1979-01-02 US disclosed
US-4057432-A PHOTOGRAPHIC COUPLERS KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) 1977-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218115-A1 MATERIALS HAVING ELECTRON DEFICIENT MOIETIES AND METHODS OF SYNTHESIZING THEREOF NBAS, EMD, MPO USP8 3662/4885USP7 4137/4885PPOX 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.